FDA Approval Activities for this Drug
CHLOROTHIAZIDE Suspension; 250MG/5ML DIURIL MERCK
| 011145 CHLOROTHIAZIDE Tablet; 250MG DIURIL MERCK
| 011145 CHLOROTHIAZIDE Tablet; 500MG DIURIL MERCK
| 084388 CHLOROTHIAZIDE Tablet; 250MG CHLOROTHIAZIDE Mylan
| 084217 CHLOROTHIAZIDE Tablet; 500MG CHLOROTHIAZIDE Mylan
| 086028 CHLOROTHIAZIDE Tablet; 250MG CHLOROTHIAZIDE West Ward
| 087736 CHLOROTHIAZIDE Tablet; 500MG CHLOROTHIAZIDE West Ward
| 011145 CHLOROTHIAZIDE SODIUM Injection 500MG BASE/VIAL DIURIL MERCK
| 011635 BP CHLOROTHIAZIDE; RESERPINE Tablet; 250MG;0.125MG DIUPRES-250 MERCK
| 011635 BP CHLOROTHIAZIDE; RESERPINE Tablet; 500MG;0.125MG DIUPRES-500 | Diuril (chlorothiazide) Intravenous Injection Merck & Co., Inc, Labeling Revision
| Diuril (chlorothiazide) Oral Suspension Merck & Co., Inc, Labeling Revision
| Diuril (chlorothiazide) Tablets Merck & Co., Inc, Labeling Revision | Diruil (chlorothiazide) intravenous Injection and tablets, Merck & Co., Labeling Revision | Diuril (chlorothiazide) Tablets, Merck & Co., Labeling Revision | Diuril (chlorothiazide) Suspension, Merck & Co., Labeling Revision | Diuril Chlorothiazide Oral Suspension, Salix Pharma, Labeling Revision | Diuril (chlorothiazide) Oral Suspension, Salix Pharmaceuticals, Inc., Labeling Revision | Chlorothiazide Sodium Injection, APP Pharmaceuticals, LLC, Approval